Dalaal M. Abdallah

Kasr El Aini Street
Cairo, C 11562, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Corrigendum to "Chloroquine modulates the sulforaphane anti-obesity mechanisms in a high-fat diet model: Role of JAK-2/ STAT-3/ SOCS-3 pathway" [EJP 927 (2022) 175066].

Corrigendum to "Chloroquine modulates the sulforaphane anti-obesity mechanisms in a high-fat diet model: Role of JAK-2/ STAT-3/ SOCS-3 pathway" [EJP 927 (2022) 175066].

Journal: European journal of pharmacology

Published: August 28, 2026

SP/NK-1 pathogenic signaling drives doxorubicin nephrotoxicity: Novel therapeutic role of MK-0869 via modulation of α-Klotho, RAS, and Wnt/β-catenin trajectories.

SP/NK-1 pathogenic signaling drives doxorubicin nephrotoxicity: Novel therapeutic role of MK-0869 via modulation of α-Klotho, RAS, and Wnt/β-catenin trajectories.

Journal: Life sciences

Published: December 17, 2025

Xanthenone Orchestrates the Renin-Angiotensin System/Ferroptosis Crosstalk: A Novel AT2R-Dependent Strategy Against Lower Limb Transient Ischemia-Induced Liver Injury.

Xanthenone Orchestrates the Renin-Angiotensin System/Ferroptosis Crosstalk: A Novel AT2R-Dependent Strategy Against Lower Limb Transient Ischemia-Induced Liver Injury.

Journal: Archiv der Pharmazie

Published: August 11, 2025

Liraglutide orchestrates ferroptosis defense against murine cisplatin acute kidney injury: NRF2 activation via both KEAP1-dependent and -independent mechanisms is essential for SLC7A11/GPX4 renoprotection.

Liraglutide orchestrates ferroptosis defense against murine cisplatin acute kidney injury: NRF2 activation via both KEAP1-dependent and -independent mechanisms is essential for SLC7A11/GPX4 renoprotection.

Journal: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)

Published: June 25, 2025

Ticagrelor as a dual RAS modulator and mitochondrial stabilizer: A multifaceted neurotherapeutic strategy in Huntington's disease.

Ticagrelor as a dual RAS modulator and mitochondrial stabilizer: A multifaceted neurotherapeutic strategy in Huntington's disease.

Journal: Neuropharmacology

Published: June 16, 2025

Parthanatos drives cognitive decline in repeated brain trauma: MSC-derived exosomes as a novel therapeutic strategy.

Parthanatos drives cognitive decline in repeated brain trauma: MSC-derived exosomes as a novel therapeutic strategy.

Journal: Frontiers in pharmacology

Published: May 09, 2025

From liver to kidney: Telmisartan attenuates NLRP3 inflammasome-driven systemic inflammation and the iNOS/Hsp70 axis partially via the Mas receptor in a hepatic ischemia-reperfusion model.

From liver to kidney: Telmisartan attenuates NLRP3 inflammasome-driven systemic inflammation and the iNOS/Hsp70 axis partially via the Mas receptor in a hepatic ischemia-reperfusion model.

Journal: European journal of pharmacology

Published: April 04, 2025

GPER1 Mediates Hippocampal Therapeutic Effect of Prunetin in Uremic Encephalopathy: Modulation of the RUNX2 Axis, TLR4 Cascade, Necroptosis, and Mitochondrial Dysfunction.

GPER1 Mediates Hippocampal Therapeutic Effect of Prunetin in Uremic Encephalopathy: Modulation of the RUNX2 Axis, TLR4 Cascade, Necroptosis, and Mitochondrial Dysfunction.

Journal: Archiv der Pharmazie

Published: March 26, 2025

Chaperone-mediated autophagy, heat shock protein 70, and serotonin: novel targets of beta-hydroxybutyrate in HFFD/LPS-induced sporadic Alzheimer's disease model.

Chaperone-mediated autophagy, heat shock protein 70, and serotonin: novel targets of beta-hydroxybutyrate in HFFD/LPS-induced sporadic Alzheimer's disease model.

Journal: Inflammopharmacology

Published: February 18, 2025

Antiplatelet therapy as a novel approach in Parkinson's disease: Repositioning Ticagrelor to alleviate rotenone-induced parkinsonism via modulation of ER stress, apoptosis, and autophagy.

Antiplatelet therapy as a novel approach in Parkinson's disease: Repositioning Ticagrelor to alleviate rotenone-induced parkinsonism via modulation of ER stress, apoptosis, and autophagy.

Journal: Neuropharmacology

Published: December 06, 2024

Retraction notice to "Vitamin D and rosuvastatin obliterate peripheral neuropathy in a type-2 diabetes model through modulating Notch1, Wnt-10α, TGF-β and NRF-1 crosstalk" [Life Sci. 279 (2021) 119697].

Retraction notice to "Vitamin D and rosuvastatin obliterate peripheral neuropathy in a type-2 diabetes model through modulating Notch1, Wnt-10α, TGF-β and NRF-1 crosstalk" [Life Sci. 279 (2021) 119697].

Journal: Life sciences

Published: November 22, 2024

Dual inhibition of canonical and noncanonical PAR-1 by SCH79797 mitigates neurodegeneration in 3-NP-induced Huntington's disease: An in vivo and in silico approach.

Dual inhibition of canonical and noncanonical PAR-1 by SCH79797 mitigates neurodegeneration in 3-NP-induced Huntington's disease: An in vivo and in silico approach.

Journal: Archiv der Pharmazie

Published: October 28, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026